Trials / Recruiting
RecruitingNCT06810375
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- George Washington University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erector Spinae (ESP) Block with Bupivacaine (Marcaine®) | preoperative erector spinae block with bupivacaine (Marcaine®) |
| DRUG | Intercostal nerve block | intraoperative intercostal nerve block with liposomal bupivacaine (Exparel®) |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2028-02-28
- Completion
- 2029-02-28
- First posted
- 2025-02-05
- Last updated
- 2026-04-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06810375. Inclusion in this directory is not an endorsement.